AUCs of 0.70, 0.72. and 0.66 at expression >1, >5, and >90%; potential prediction of response to PD‐1 or PD‐L1 treatment, pneumonia development, and patient survival. This evidence concerns the gene CD274 and susceptibility to pneumonia measurement.